Sen. Chuck Grassley

Maddy summaryThis resolution designates April 21-25, 2025, as "National Home Visiting Week" to recognize home visiting programs. It does not create new policies or allocate funds; instead, it formally acknowledges the work of these programs through Senate support. The resolution references existing program data (e.g., 2023 service statistics) but has no direct effect on families or providers. It serves as a symbolic gesture to highlight the role of home visiting in early childhood development.

Maddy summarySRES 186 designates April 29, 2025, as National Fentanyl Awareness Day to raise public awareness about the dangers of counterfeit fentanyl pills. The resolution specifically aims to inform families and young people about how fake pills - often disguised as legitimate medications - contribute to overdose deaths, citing that illicit fentanyl was involved in 81% of drug deaths among youth aged 14-23 in 2023. It does not create new laws or funding but formally supports existing efforts to combat counterfeit pills and encourages awareness campaigns. The resolution highlights alarming statistics, including 51,010 fentanyl-related overdose deaths in 2024 and low youth awareness (only 55% of teens knew about counterfeit pills).

Maddy summaryThis bill amends the Immigration and Nationality Act to expand the definition of "aggravated felonies" by adding "sexual assault and aggravated sexual violence" to the list of crimes triggering mandatory deportation for non-citizens. It directly affects non-citizens convicted of these specific sexual offenses, making them subject to automatic deportation under immigration law. The key change is adding this provision to Section 101(a)(43) of the Immigration and Nationality Act, which defines aggravated felonies. This policy shift would expand the scope of offenses classified as deportation triggers without creating new enforcement procedures.

Maddy summaryThis symbolic Senate resolution (SRES 179) formally recognizes April 2025 as National Sexual Assault Awareness and Prevention Month. It endorses the month's goals of educating the public about sexual violence, preventing future assaults, improving support for survivors, and ensuring perpetrators face accountability. The resolution does not create new laws or allocate funding but publicly affirms the Senate's commitment to these objectives. It specifically highlights the work of organizations like RAINN and local rape crisis centers that support survivors, while citing statistics on sexual violence prevalence to underscore the importance of awareness efforts.

Maddy summaryThe Combating Organized Retail Crime Act amends federal law to strengthen legal tools for addressing organized retail crime, including theft from stores, online, and supply chains. It establishes a new Organized Retail and Supply Chain Crime Coordination Center within the Department of Homeland Security to coordinate Federal, State, local, and tribal law enforcement efforts. The Center will share information, assist with investigations, track crime trends, and provide training to combat these crimes. The bill expands legal definitions to include organized retail crime as a specific category and requires annual reports on the Center's activities. The Center will operate for 7 years before sunset.

Maddy summaryS 1418 requires federal agencies to produce three reports analyzing data on threats to law enforcement officers and their well-being. The bill mandates a report on violent attacks (including ambushes) against officers, current training programs, and gaps in gear distribution; a report on adding a new category for non-criminal aggressive incidents against officers; and a report on mental health impacts and available support resources. These reports, due 270 days after enactment, will assess data collection systems, resource effectiveness, and disparities in reporting. The bill directly affects federal, state, and local law enforcement agencies by requiring them to contribute data and shape future safety policies. Its goal is to inform better resource allocation and training based on comprehensive data, not to mandate immediate changes.

Maddy summaryThis bill amends federal meat and poultry inspection laws to allow state-inspected meat and poultry products to be sold across state lines. It removes the previous restriction that limited such products to sales only within the state where they were inspected, enabling interstate commerce for products meeting state inspection standards. The bill requires the Secretary of Agriculture to permit interstate shipments of properly inspected state products and prohibits states from blocking the movement or sale of these items. It directly affects small meat and poultry producers, processors, and retailers who rely on state inspection programs instead of federal oversight. The change aims to expand market access for these businesses without altering inspection standards.

Maddy summaryThis bill prohibits "reverse payment" agreements where brand-name drug companies pay generic or biosimilar manufacturers to delay entering the market, which harms competition. It creates a presumption that such agreements are anticompetitive if a generic or biosimilar company receives value in exchange for delaying market entry, with exceptions for standard settlements involving early market entry rights or reasonable litigation expenses. The bill amends the Federal Trade Commission Act to enforce this new prohibition and requires certification of such agreements, aiming to enhance competition and lower drug costs for consumers. This would directly affect brand-name drug companies, generic manufacturers, and biosimilar biological product manufacturers.

Maddy summaryThe Stop STALLING Act empowers the Federal Trade Commission (FTC) to take action against pharmaceutical companies that submit "sham" petitions under drug approval processes. Specifically, it targets petitions that are objectively baseless and used to delay generic drug approvals, directly affecting drug manufacturers filing such petitions. The bill establishes civil penalties of up to $50,000 per day or the revenue earned from the delayed drug during the petition's review period. It creates a presumption of "sham" status if the Health Secretary determines a petition was filed primarily to delay approval, with companies able to rebut this presumption. The law does not alter FDA drug approval rules but adds FTC enforcement for unfair competition tactics.

Maddy summaryThe provided context does not include a substantive summary or bill text beyond the short title. Without details on the bill's specific provisions, mechanisms, or affected parties, a factual summary cannot be generated. The title "Interagency Patent Coordination and Improvement Act of 2025" suggests a focus on federal patent processes, but no concrete policy changes are described in the given text. For an accurate summary, the full bill language or official summary would be required.